|
Detoxamin 1000 mg EDTA Suppositories
Replaced By: Kelatox or Medicardium Detoxamin has been closed by the FDA, we do not expect them to come back.
All of the proven benefits of IV EDTA Chelation, none of the disadvantages.
Scientific & Clinical Advantages:
- The only EDTA suppository formula with bio-available studies
- High absorption and tissue concentration is proven in high tech
- lab analysis
- 2.5 million doses administered worldwide
- Currently involved in three IRB, FDA sanctioned studies
- The only EDTA suppository manufactured by an FDA approved
- GMP facility
- 2,500 doctors and clinicians worldwide use Detoxamin
- 50,000 patients and consumers have used Detoxamin
Other Advantages:
- 70% less than IV EDTA chelation therapy
- Non-invasive, no discomfort, no hassle
- No inconvenient, time consuming doctor visits
- Introduces less EDTA dosage, but lasts longer
- Safer than IV EDTA
- Well-tolerated by adults and children
|